Biophysical basis of the binding of WWOX tumor suppressor to WBP1 and WBP2 adaptors

Journal of Molecular Biology

Volumn 422, Issue 1, 2012, Pages 58-74

  McDonald, Caleb B ^a,b   Buffa, Laura ^a,b   Bar Mag, Tomer ^c   Salah, Zaidoun ^c   Bhat, Vikas ^a,b   Mikles, David C ^a,b   Deegan, Brian J ^a,b   Seldeen, Kenneth L ^a,b   Malhotra, Arun ^a   Sudol, Marius ^d,e   Aqeilan, Rami I ^c   Nawaz, Zafar ^a,b   Farooq, Amjad ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d WEIS CENTER FOR RESEARCH   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

WW domain chaperone; WW domain engineering; WW tandem domains; WW ligand thermodynamics

Indexed keywords

BINDING PROTEIN; CHAPERONE; LIGAND; OXIDOREDUCTASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WW BINDING PROTEIN 1; WW BINDING PROTEIN 2; WW CONTAINING OXIDOREDUCTASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; WILD TYPE;

EID: 84864623653     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.05.015     Document Type: Article

References (59)

1. Del Mare S., Salah Z., and Aqeilan R.I. WWOX: its genomics, partners, and functions J. Cell. Biochem. 108 2009 737 745
2. Bednarek A.K., Laflin K.J., Daniel R.L., Liao Q., Hawkins K.A., and Aldaz C.M. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer Cancer Res. 60 2000 2140 2145
3. Bednarek A.K., Keck-Waggoner C.L., Daniel R.L., Laflin K.J., Bergsagel P.L., and Kiguchi K. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth Cancer Res. 61 2001 8068 8073
4. Hezova R., Ehrmann J., and Kolar Z. WWOX, a new potential tumor suppressor gene Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 151 2007 11 15
5. Nunez M.I., Ludes-Meyers J., Abba M.C., Kil H., Abbey N.W., and Page R.E. Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status Breast Cancer Res. Treat. 89 2005 99 105
6. Aqeilan R.I., Kuroki T., Pekarsky Y., Albagha O., Trapasso F., and Baffa R. Loss of WWOX expression in gastric carcinoma Clin. Cancer Res. 10 2004 3053 3058
7. Aqeilan R.I., and Croce C.M. WWOX in biological control and tumorigenesis J. Cell. Physiol. 212 2007 307 310
8. Aqeilan R.I., Hagan J.P., Aqeilan H.A., Pichiorri F., Fong L.Y., and Croce C.M. Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo Cancer Res. 67 2007 5606 5610
9. Pluciennik E., Kusinska R., Potemski P., Kubiak R., Kordek R., and Bednarek A.K. WWOX - the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis Eur. J. Surg. Oncol. 32 2006 153 157
10. Lewandowska U., Zelazowski M., Seta K., Byczewska M., Pluciennik E., and Bednarek A.K. WWOX, the tumour suppressor gene affected in multiple cancers J. Physiol. Pharmacol. 60 2009 47 56
11. Zelazowski M.J., Pluciennik E., Pasz-Walczak G., Potemski P., Kordek R., and Bednarek A.K. WWOX expression in colorectal cancer - a real-time quantitative RT-PCR study Tumour Biol. 32 2011 551 560
12. Aqeilan R.I., Trapasso F., Hussain S., Costinean S., Marshall D., and Pekarsky Y. Targeted deletion of Wwox reveals a tumor suppressor function Proc. Natl Acad. Sci. USA 104 2007 3949 3954
13. Aqeilan R.I., Hassan M.Q., de Bruin A., Hagan J.P., Volinia S., and Palumbo T. The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism J. Biol. Chem. 283 2008 21629 21639
14. Aqeilan R.I., Hagan J.P., de Bruin A., Rawahneh M., Salah Z., and Gaudio E. Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis Endocrinology 150 2009 1530 1535
15. Aqeilan R.I., Palamarchuk A., Weigel R.J., Herrero J.J., Pekarsky Y., and Croce C.M. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor Cancer Res. 64 2004 8256 8261
16. Aqeilan R.I., Pekarsky Y., Herrero J.J., Palamarchuk A., Letofsky J., and Druck T. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog Proc. Natl Acad. Sci. USA 101 2004 4401 4406
17. Aqeilan R.I., Donati V., Palamarchuk A., Trapasso F., Kaou M., and Pekarsky Y. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function Cancer Res. 65 2005 6764 6772
18. Ludes-Meyers J.H., Kil H., Bednarek A.K., Drake J., Bedford M.T., and Aldaz C.M. WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins Oncogene 23 2004 5049 5055
19. Einbond A., and Sudol M. Towards prediction of cognate complexes between the WW domain and proline-rich ligands FEBS Lett. 384 1996 1 8
20. Sudol M. Structure and function of the WW domain Prog. Biophys. Mol. Biol. 65 1996 113 132
21. Sudol M WW domain G.G. Cesareni, M. Gimona, M. Sudol, M. Yaffe, Modular Protein Domains 2004 Wiley VCH, Verlag GmbH & Co Weinheim, Germany 59 72
22. Yagi R., Chen L.F., Shigesada K., Murakami Y., and Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator EMBO J. 18 1999 2551 2562
23. Komuro A., Nagai M., Navin N.E., and Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus J. Biol. Chem. 278 2003 33334 33341
24. Zhao B., Ye X., Yu J., Li L., Li W., and Li S. TEAD mediates YAP-dependent gene induction and growth control Genes Dev. 22 2008 1962 1971
25. Hao Y., Chun A., Cheung K., Rashidi B., and Yang X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP J. Biol. Chem. 283 2008 5496 5509
26. Zhao B., Wei X., Li W., Udan R.S., Yang Q., and Kim J. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev. 21 2007 2747 2761
27. Bertini E., Oka T., Sudol M., Strano S., and Blandino G. YAP: at the crossroad between transformation and tumor suppression Cell Cycle 8 2009 49 57
28. Sudol M. Newcomers to the WW domain-mediated network of the hippo tumor suppressor pathway Genes Cancer 1 2010 1115 1118
29. Sudol M., and Harvey K.F. Modularity in the Hippo signaling pathway Trends Biochem. Sci. 35 2010 627 633
30. Salah Z., Alian A., and Aqeilan R.I. WW domain-containing proteins: retrospectives and the future Front. Biosci. 17 2012 331 348
31. Pires J.R., Taha-Nejad F., Toepert F., Ast T., Hoffmuller U., and Schneider-Mergener J. Solution structures of the YAP65 WW domain and the variant L30 K in complex with the peptides GTPPPPYTVG, N-(n-octyl)-GPPPY and PLPPY and the application of peptide libraries reveal a minimal binding epitope J. Mol. Biol. 314 2001 1147 1156
32. McDonald C.B., McIntosh S.K., Mikles D.C., Bhat V., Deegan B.J., and Seldeen K.L. Biophysical analysis of binding of WW domains of the YAP2 transcriptional regulator to PPXY motifs within WBP1 and WBP2 adaptors Biochemistry 50 2011 9616 9627
33. Macias M.J., Hyvonen M., Baraldi E., Schultz J., Sudol M., Saraste M., and Oschkinat H. Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide Nature 382 1996 646 649
34. Huang X., Poy F., Zhang R., Joachimiak A., Sudol M., and Eck M.J. Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan Nat. Struct. Biol. 7 2000 634 638
35. Kanelis V., Rotin D., and Forman-Kay J.D. Solution structure of a Nedd4 WW domain-ENaC peptide complex Nat. Struct. Biol. 8 2001 407 412
36. Fernandez-Escamilla A.M., Ventura S., Serrano L., and Jimenez M.A. Design and NMR conformational study of a beta-sheet peptide based on Betanova and WW domains Protein Sci. 15 2006 2278 2289
37. Jager M., Dendle M., and Kelly J.W. Sequence determinants of thermodynamic stability in a WW domain - an all-beta-sheet protein Protein Sci. 18 2009 1806 1813
38. Tapia V.E., Nicolaescu E., McDonald C.B., Musi V., Oka T., and Inayoshi Y. Y65C missense mutation in the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1 affects its binding activity and deregulates pre-mRNA splicing J. Biol. Chem. 285 2010 19391 19401
39. Salah Z., Melino G., and Aqeilan R.I. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity Cancer Res. 71 2011 2010 2020
40. Salah Z., and Aqeilan R.I. WW domain interactions regulate the Hippo tumor suppressor pathway Cell Death Dis. 2 2011 e172
41. Ho K.C., Zhou Z., She Y.M., Chun A., Cyr T.D., and Yang X. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability Proc. Natl Acad. Sci. USA 108 2011 4870 4875
42. Fedoroff O.Y., Townson S.A., Golovanov A.P., Baron M., and Avis J.M. The Structure and dynamics of tandem WW domains in a negative regulator of notch signaling, suppressor of deltex J. Biol. Chem. 279 2004 34991 35000
43. Feng W., Shi Y., Li M., and Zhang M. Tandem PDZ repeats in glutamate receptor-interacting proteins have a novel mode of PDZ domain-mediated target binding Nat. Struct. Biol. 10 2003 972 978
44. Gaudio E., Palamarchuk A., Palumbo T., Trapasso F., Pekarsky Y., Croce C.M., and Aqeilan R.I. Physical association with WWOX suppresses c-Jun transcriptional activity Cancer Res. 66 2006 11585 11589
45. Gao X., Yo P., Keith A., Ragan T.J., and Harris T.K. Thermodynamically balanced inside-out (TBIO) PCR-based gene synthesis: a novel method of primer design for high-fidelity assembly of longer gene sequences Nucleic Acids Res. 31 2003 e143
46. Gasteiger E., Hoogland C., Gattiker A., Duvaud S., Wilkins M.R., Appel R.D., and Bairoch A. Protein identification and analysis tools on the ExPASy server J.M. Walker, The Proteomics Protocols Handbook 2005 Humana Press Totowa, NJ 571 607
47. Wiseman T., Williston S., Brandts J.F., and Lin L.N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter Anal. Biochem. 179 1989 131 137
48. Privalov P.L., and Potekhin S.A. Scanning microcalorimetry in studying temperature-induced changes in proteins Methods Enzymol. 131 1986 4 51
49. Privalov G.P., and Privalov P.L. Problems and prospects in microcalorimetry of biological macromolecules Methods Enzymol. 323 2000 31 62
50. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., and Sali A. Comparative protein structure modeling of genes and genomes Annu. Rev. Biophys. Biomol. Struct. 29 2000 291 325
51. Carson M. Ribbons 2.0 J. Appl. Crystallogr. 24 1991 958 961
52. Van Der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., and Berendsen H.J. GROMACS: fast, flexible, and free J. Comput. Chem. 26 2005 1701 1718
53. Hess B. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation J. Chem. Theory Comput. 4 2008 435 447
54. Jorgensen W.L., and Tirado-Rives J. The OPLS force field for proteins: energy minimizations for crystals of cyclic peptides and crambin J. Am. Chem. Soc. 110 1988 1657 1666
55. Kaminski G.A., Friesner R.A., Tirado-Rives J., and Jorgensen W.L. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides J. Phys. Chem. B 105 2001 6474 6487
56. Toukan K., and Rahman A. Molecular-dynamics study of atomic motions in water Phys. Rev. B 31 1985 2643 2648
57. Berendsen H.J.C., Grigera J.R., and Straatsma T.P. The missing term in effective pair potentials J. Phys. Chem. 91 1987 6269 6271
58. Darden T.A., York D., and Pedersen L. Particle mesh Ewald: an N.log(N) method for Ewald sums in large systems J. Chem. Phys. 98 1993 10089 10092
59. Hess B., Bekker H., Berendsen H.J.C., and Fraaije J.G.E.M. LINCS: a linear constraint solver for molecular simulations J. Comput. Chem. 18 1997 1463 1472